All Curated Mutation Sites in HIV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All
  
IN
  
RT
  
LTR
  
CA
  
Gag
  
Nef
  
Env
  
gp120
  
gp160
  
gp41
  
gp140
  
MA
  
Pol
  
PR
  
Rev
  
Tat
  
Vpu
  
Vif
  
Vpr
  

Keyword: HIV Infections-30409215
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 30409215 A62V
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
2 30409215 D67G
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
3 30409215 D67N
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
4 30409215 E138K
IN
gag-pol
HIV Infections
D
G
R
S
C
L
View
5 30409215 E157Q
IN
gag-pol
HIV Infections
D
G
R
S
C
L
View
6 30409215 E35G
PR
gag-pol
HIV Infections
D
G
R
S
C
L
View
7 30409215 E44D
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
8 30409215 E92G
IN
gag-pol
HIV Infections
D
G
R
S
C
L
View
9 30409215 E92Q
IN
gag-pol
HIV Infections
D
G
R
S
C
L
View
10 30409215 E92V
IN
gag-pol
HIV Infections
D
G
R
S
C
L
View
11 30409215 F53L
PR
gag-pol
HIV Infections
D
G
R
S
C
L
View
12 30409215 G163R
IN
gag-pol
HIV Infections
D
G
R
S
C
L
View
13 30409215 I50V
PR
gag-pol
HIV Infections
D
G
R
S
C
L
View
14 30409215 K103N
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
15 30409215 K103R
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
16 30409215 K20I
PR
gag-pol
HIV Infections
D
G
R
S
C
L
View
17 30409215 K219Q
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
18 30409215 K65R
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
19 30409215 L100I
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
20 30409215 L10F
PR
gag-pol
HIV Infections
D
G
R
S
C
L
View
21 30409215 L210W
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
22 30409215 L74I
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
23 30409215 L74M
IN
gag-pol
HIV Infections
D
G
R
S
C
L
View
24 30409215 M184I
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
25 30409215 M184V
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
26 30409215 M41L
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
27 30409215 M46I
PR
gag-pol
HIV Infections
D
G
R
S
C
L
View
28 30409215 M46L
PR
gag-pol
HIV Infections
D
G
R
S
C
L
View
29 30409215 P225H
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
30 30409215 Q148K
IN
gag-pol
HIV Infections
D
G
R
S
C
L
View
31 30409215 Q58E
PR
gag-pol
HIV Infections
D
G
R
S
C
L
View
32 30409215 S147G
IN
gag-pol
HIV Infections
D
G
R
S
C
L
View
33 30409215 T215Y
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
34 30409215 T66I
IN
gag-pol
HIV Infections
D
G
R
S
C
L
View
35 30409215 T74S
PR
gag-pol
HIV Infections
D
G
R
S
C
L
View
36 30409215 T97A
IN
gag-pol
HIV Infections
D
G
R
S
C
L
View
37 30409215 V11I
PR
gag-pol
HIV Infections
D
G
R
S
C
L
View
38 30409215 V188I
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
39 30409215 V75I
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
40 30409215 Y188C
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
41 30409215 Y318F
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.